You are here



  • Investigate all reports of active or suspected cases of Tuberculosis
  • Ensure required follow-up has been done on all reported positive TB skin tests
  • Provide TB skin testing at our clinics
  • Provide free TB medication for prophylaxis and treatment
  • Provide information, advice on the management of LTBI and Active TB cases to healthcare providers
  • Provide multilingual resources on TB
  • Follow-up of persons under medical surveillance for Tuberculosis

Public Health TB clinics

  • Offered one Thursday per month at our Guelph 160 Chancellors Way location
  • Staffed by a respirologist and public health nurses
  • We welcome written referrals from physicians and nurse practitioners. Please fax referrals to the Reportable Disease secure fax line at 1-855-WDG-LINE (1-855-934-5463)

Reporting Requirements

Tuberculosis is a reportable disease under the Health Protection and Promotion Act - R.S.O. 1990, Chapter H.7.

All physicians, laboratories, institutions, hospital administrators, and schools must report all persons with any of the following to Public Health:

  • Latent TB infection
  • Suspected active TB
  • Confirmed active TB

To report a positive Mantoux TB skin test result, use this form: Reporting Mantoux TB Skin Test (PDF).

Practice Guidelines and Resources

For detailed information on current and past BCG policies and practices for over 180 countries.

A useful tool to estimate the risk of active tuberculosis for person with TB skin tests of 5mm+.

Forms and fact sheets

Reporting and Screening:

TB Testing and Medication:

TB Fact Sheets:

Interferon Gamma Release Assays (IGRA Testing)

Two Interferon Gamma Release Assays (IGRAs) are licensed for use in Canada:

  • Quantiferon TB Gold (available through Gamma-Dynacare commercial laboratories)
  •  T-SPOT TB

These tests are not covered under the Ontario Health Insurance Plan (OHIP) and cost approximately $90 each.

For more information:

Additional Resources

No additional resources found